Cromos Pharma, where the patients are

R&D Trends

Report: Inventor incentives could spur medical innovation, cut spending

Wednesday, April 23, 2014 01:55 PM

To help rein in massive healthcare spending, a new RAND study concludes U.S. policymakers should urgently find ways to incentivize pharmaceutical companies and device makers to develop products that produce more value. RAND is a research organization that develops solutions to public policy challenges.

More... »

CRF Health eCOA webinar series

Scripps Florida Scientists awarded $2M for anti-diabetic drug design

Wednesday, April 23, 2014 01:46 PM

The NIH has awarded scientists from the Florida campus of The Scripps Research Institute (TSRI) $2.1 million to study the therapeutic potential of safer and more effective alternatives to the current crop of anti-diabetic drugs, which have been limited in their use due to side effects including bone loss and congestive heart failure.

More... »


GSK, Novartis, Eli Lilly swap assets to specialize, become more profitable

Wednesday, April 23, 2014 08:42 AM

In a major swap of assets, three of the world’s largest drug companies have announced a multi-part, $28.5 billion deal that enables Novartis to focus more on cancer, GlaxoSmithKline on vaccines and Eli Lilly on animal health.

More... »

Report: Total VC investment in Q1 2014 highest since 2001

Monday, April 21, 2014 02:34 PM

Venture capitalists invested $9.5 billion in 951 deals in the first quarter of 2014, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and the National Venture Capital Association (NVCA), based on data provided by Thomson Reuters

More... »

Report: Global umbilical cord blood stem cell market to reach $56.4B by 2020

Monday, April 21, 2014 09:41 AM

Allied Market Research has reported that the global umbilical cord blood stem cell market is forecasted to reach market value over $11.5 billion in 2014 from $ 6.5 billion in 2012.

More... »

AMRI shutters New York research center, cuts 45 jobs

Friday, April 18, 2014 12:39 PM

Albany Molecular Research (AMRI), a global contract research and manufacturing organization, will be transitioning Discovery and Development Services (DDS) activities at its Syracuse, N.Y., site to other sites within AMRI and will cease operations in Syracuse by the end of June.

More... »

Report: Biomarker market for diagnostic applications to reach $30.6B globally by 2020

Friday, April 18, 2014 12:31 PM

According to a new report from Allied Market Research, the global biomarkers market for diagnostic applications such as risk assessment, molecular diagnostic, disease diagnosis, drug discovery and development, drug formulation, forensic and other such applications is set to reach about $30.6 billion in 2020, growing at CAGR of 16% from 2013 to 2020.

More... »

Report: Anti-counterfeit packaging market to reach $142.7B by 2020

Thursday, April 17, 2014 11:20 AM

According to a new report by Allied Market Research titled Anti-counterfeit Packaging Market in Food and Pharmaceuticals—Technologies, Applications and Global Forecast through 2020, the global anti-counterfeit packaging market in food and pharmaceuticals is forecast to attain market value of $142.7 billion by 2020, from $57.4 billion in 2013, growing at 13.9% CAGR from 2013 to 2020. Technological advancements and government initiatives to curb counterfeiting is expected to drive the market growth.

More... »

Kineta, RLB Holdings form joint venture for high-need therapeutics

Wednesday, April 16, 2014 01:43 PM

Kineta, a biotechnology company focused on the development of immune-modulating drugs for critical diseases, and RLB Holdings, an investment fund founded by Ray and Lydia Bartoszek, have formed a joint venture, Kineta RLB, which will commercialize promising, high-value compounds in selective disease areas with unmet medical needs.

More... »

Scripps Research Institute launches drug discovery initiative Scripps Advance

Monday, April 14, 2014 03:02 PM

The Scripps Research Institute (TSRI) has announced the formation of Scripps Advance, a new drug discovery initiative to translate early-stage biomedical research projects, both internal and external to TSRI, into clinical development candidates. Scripps Advance's first collaborator in this new endeavor is the Johnson & Johnson Innovation Center in California.

More... »

CenterWatch Drugs in Clinical Trials
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs